KEGG   DRUG: Dolutegravir - avacavir - lamivudine mixtHelp
Entry
D10600            Mixture   Drug                                   

Name
Dolutegravir - avacavir - lamivudine mixt;
Triumeq (TN)
Product
Component
(Dolutegravir sodium [DR:D10113] | Dolutegravir [DR:D10066]), Abacavir sulfate [DR:D00891], Lamivudine [DR:D00353]
Remark
Therapeutic category: 6250
ATC code: J05AR13
Product: D10600<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR13 Lamivudine, abacavir and dolutegravir
      D10600  Dolutegravir - avacavir - lamivudine mixt <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10600  Dolutegravir - avacavir - lamivudine mixt
Antiinfectives [br08350.html]
 Antivirals
  D10600
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10600
BRITE hierarchy
Other DBs
PubChem: 254741562
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system